Compile Data Set for Download or QSAR
maximum 50k data
Found 109 with Last Name = 'manaka' and Initial = 'a'
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50098965(3-{2-[(Z)-4-Carbamimidoyl-benzoylimino]-3,4-dimeth...)
Affinity DataKi:  0.0460nMAssay Description:Binding to [125I]- fibrinogen by washed platelet fibrinogen receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosinase(Mus musculus (Mouse))
National Institute Of Advanced Industrial Science And Technology

Curated by ChEMBL
LigandPNGBDBM50414514(PROTOCATECHUAMIDE)
Affinity DataKi:  3.70E+3nMAssay Description:Apparent noncompetitive inhibition of catecholase activity of tyrosinase in mouse B16 cells by Lineweaver-Burke plot analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosinase(Mus musculus (Mouse))
National Institute Of Advanced Industrial Science And Technology

Curated by ChEMBL
LigandPNGBDBM50296245(3,4-Dihydroxy-N-[2-(5-hydroxyindol-3-yl)ethyl]benz...)
Affinity DataKi:  6.40E+4nMAssay Description:Apparent noncompetitive inhibition of catecholase activity of tyrosinase in mouse B16 cells by Lineweaver-Burke plot analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosinase(Mus musculus (Mouse))
National Institute Of Advanced Industrial Science And Technology

Curated by ChEMBL
LigandPNGBDBM29612(CHEMBL33103 | CVD-0001578 | JOH-MSK-a63bdd1d-4 | N...)
Affinity DataKi:  2.40E+5nMAssay Description:Apparent noncompetitive inhibition of catecholase activity of tyrosinase in mouse B16 cells by Lineweaver-Burke plot analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50098965(3-{2-[(Z)-4-Carbamimidoyl-benzoylimino]-3,4-dimeth...)
Affinity DataIC50:  0.0900nMAssay Description:Affinity for purified activated GPIIb/IIIa fibrinogen receptor in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50098971(3-({3-Benzyl-2-[(Z)-4-carbamimidoyl-benzoylimino]-...)
Affinity DataIC50:  0.0900nMAssay Description:Affinity for purified activated GPIIb/IIIa fibrinogen receptor in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50098967(3-({2-[(Z)-4-Carbamimidoyl-benzoylimino]-3-ethyl-4...)
Affinity DataIC50:  0.120nMAssay Description:Inhibition of immobilized HUVEC adhesion on fibronectinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50098964(3-({3-Butyl-2-[(Z)-4-carbamimidoyl-benzoylimino]-4...)
Affinity DataIC50:  0.130nMAssay Description:Binding to [125I]- fibrinogen by washed platelet fibrinogen receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50098966(3-[3-(4-Carbamimidoyl-benzoylamino)-phenyl]-propio...)
Affinity DataIC50:  0.550nMAssay Description:In vitro inhibition of ADP (2 microM) induced platelet aggregation of human platelet rich plasmaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50098969(3-[2-(4-Carbamimidoyl-benzoylamino)-4-methyl-thiaz...)
Affinity DataIC50:  0.570nMAssay Description:In vitro inhibition of ADP (3 microM)induced platelet aggregation of guinea pig platelet rich plasmaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50098968(3-({2-[(Z)-4-Carbamimidoyl-benzoylimino]-3,4-dimet...)
Affinity DataIC50:  0.890nMAssay Description:Inhibition of immobilized HUVEC adhesion on fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50098972(3-{2-[(4-Carbamimidoyl-benzoyl)-methyl-amino]-4-me...)
Affinity DataIC50:  1nMAssay Description:Binding to [125I]- fibrinogen by washed platelet fibrinogen receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50098970(3-{2-[(Z)-4-Carbamimidoyl-benzoylimino]-3-methyl-6...)
Affinity DataIC50:  4.80nMAssay Description:Affinity for purified activated GPIIb/IIIa fibrinogen receptor in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50098964(3-({3-Butyl-2-[(Z)-4-carbamimidoyl-benzoylimino]-4...)
Affinity DataIC50:  6.30nMAssay Description:Binding to [125I]- fibrinogen by washed platelet fibrinogen receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50098965(3-{2-[(Z)-4-Carbamimidoyl-benzoylimino]-3,4-dimeth...)
Affinity DataIC50:  11nMAssay Description:Affinity for purified activated GPIIb/IIIa fibrinogen receptor in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50098965(3-{2-[(Z)-4-Carbamimidoyl-benzoylimino]-3,4-dimeth...)
Affinity DataIC50:  17nMAssay Description:Affinity for purified activated GPIIb/IIIa fibrinogen receptor in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50098965(3-{2-[(Z)-4-Carbamimidoyl-benzoylimino]-3,4-dimeth...)
Affinity DataIC50:  21nMAssay Description:In vitro inhibition of ADP (5 microM) induced platelet aggregation of mouse platelet rich plasmaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50098965(3-{2-[(Z)-4-Carbamimidoyl-benzoylimino]-3,4-dimeth...)
Affinity DataIC50:  36nMAssay Description:Binding to [125I]- fibrinogen by washed platelet fibrinogen receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50098965(3-{2-[(Z)-4-Carbamimidoyl-benzoylimino]-3,4-dimeth...)
Affinity DataIC50:  37nMAssay Description:Binding to [125I]- fibrinogen by washed platelet fibrinogen receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50098968(3-({2-[(Z)-4-Carbamimidoyl-benzoylimino]-3,4-dimet...)
Affinity DataIC50:  52nMAssay Description:Affinity for purified activated GPIIb/IIIa fibrinogen receptor in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50098969(3-[2-(4-Carbamimidoyl-benzoylamino)-4-methyl-thiaz...)
Affinity DataIC50:  61nMAssay Description:Affinity for purified activated GPIIb/IIIa fibrinogen receptor in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50098970(3-{2-[(Z)-4-Carbamimidoyl-benzoylimino]-3-methyl-6...)
Affinity DataIC50:  68nMAssay Description:Affinity for purified activated GPIIb/IIIa fibrinogen receptor in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50098966(3-[3-(4-Carbamimidoyl-benzoylamino)-phenyl]-propio...)
Affinity DataIC50:  105nMAssay Description:Affinity for purified activated GPIIb/IIIa fibrinogen receptor in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetReceptor-type tyrosine-protein phosphatase C(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094938(5-Isopropoxy-2-(4-methylsulfanyl-pyridin-2-ylmetha...)
Affinity DataIC50:  280nMAssay Description:The compound was evaluated for its inhibitory activity towards Protein tyrosine phosphatase of CD45More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50302545((R)-1-(4-Benzoyl-2-methylpiperazin-1-yl)-2-(1H-ind...)
Affinity DataIC50:  2.60E+3nMAssay Description:Inhibition of recombinant CYP2C19More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50302545((R)-1-(4-Benzoyl-2-methylpiperazin-1-yl)-2-(1H-ind...)
Affinity DataIC50:  4.80E+3nMAssay Description:Inhibition of recombinant CYP2D6More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50302545((R)-1-(4-Benzoyl-2-methylpiperazin-1-yl)-2-(1H-ind...)
Affinity DataIC50:  5.20E+3nMAssay Description:Inhibition of recombinant CYP2C9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50302544((R)-1-(4-Benzoyl-2-methylpiperazin-1-yl)-2-(1H-pyr...)
Affinity DataIC50:  7.20E+3nMAssay Description:Inhibition of recombinant CYP2C19More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50228518((R)-1-(4-Benzoyl-2-methylpiperazin-1-yl)-2-(1H-pyr...)
Affinity DataIC50:  7.90E+3nMAssay Description:Inhibition of recombinant CYP2C9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50302543((R)-1-(4-Benzoyl-2-methylpiperazin-1-yl)-2-(1H-pyr...)
Affinity DataIC50:  9.30E+3nMAssay Description:Inhibition of recombinant CYP3A4 using 7-benzyloxyresorufin as substrateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50133282((R)-1-(4-benzoyl-2-methylpiperazin-1-yl)-2-(4-meth...)
Affinity DataIC50:  9.70E+3nMAssay Description:Inhibition of recombinant CYP2D6More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50228518((R)-1-(4-Benzoyl-2-methylpiperazin-1-yl)-2-(1H-pyr...)
Affinity DataIC50:  1.00E+4nMAssay Description:Inhibition of recombinant CYP2C19More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50228518((R)-1-(4-Benzoyl-2-methylpiperazin-1-yl)-2-(1H-pyr...)
Affinity DataIC50:  1.70E+4nMAssay Description:Inhibition of recombinant CYP2D6More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50302544((R)-1-(4-Benzoyl-2-methylpiperazin-1-yl)-2-(1H-pyr...)
Affinity DataIC50:  1.70E+4nMAssay Description:Inhibition of recombinant CYP2C9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50302543((R)-1-(4-Benzoyl-2-methylpiperazin-1-yl)-2-(1H-pyr...)
Affinity DataIC50:  1.70E+4nMAssay Description:Inhibition of recombinant CYP2C19More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50302543((R)-1-(4-Benzoyl-2-methylpiperazin-1-yl)-2-(1H-pyr...)
Affinity DataIC50:  1.80E+4nMAssay Description:Inhibition of recombinant CYP3A4 using benzyloxy-4-(trifluoromethyl)coumarin as substrateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein phosphatase non-receptor type 1(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094938(5-Isopropoxy-2-(4-methylsulfanyl-pyridin-2-ylmetha...)
Affinity DataIC50:  1.82E+4nMAssay Description:The compound was evaluated for its inhibitory activity towards Protein tyrosine phosphatase of PTP1BMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosinase(Mus musculus (Mouse))
National Institute Of Advanced Industrial Science And Technology

Curated by ChEMBL
LigandPNGBDBM50296247(3-(3,4-Dihydroxyphenyl)-N-[2-(5-hydroxyindol-3-yl)...)
Affinity DataIC50:  2.80E+4nMAssay Description:Inhibition of catecholase activity of tyrosinase in mouse B16 cells assessed as dopachrome formationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50228465(1-(4-benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-py...)
Affinity DataIC50:  3.00E+4nMAssay Description:Inhibition of recombinant CYP2C9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein phosphatase non-receptor type 1(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094936(CHEMBL86473 | Vanadate)
Affinity DataIC50:  3.02E+4nMAssay Description:The compound was evaluated for its inhibitory activity towards Protein tyrosine phosphatase of PP2AMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein phosphatase non-receptor type 1(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094936(CHEMBL86473 | Vanadate)
Affinity DataIC50:  3.08E+4nMAssay Description:The compound was evaluated for its inhibitory activity towards Protein tyrosine phosphatase of PP1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetReceptor-type tyrosine-protein phosphatase C(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094936(CHEMBL86473 | Vanadate)
Affinity DataIC50:  3.42E+4nMAssay Description:The compound was evaluated for its inhibitory activity towards Protein tyrosine phosphatase of CD45More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50302542((R)-1-(4-Benzoyl-2-methylpiperazin-1-yl)-2-(1H-pyr...)
Affinity DataIC50:  3.60E+4nMAssay Description:Inhibition of recombinant CYP2C19More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50302544((R)-1-(4-Benzoyl-2-methylpiperazin-1-yl)-2-(1H-pyr...)
Affinity DataIC50:  3.80E+4nMAssay Description:Inhibition of recombinant CYP2D6More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein phosphatase non-receptor type 1(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50094936(CHEMBL86473 | Vanadate)
Affinity DataIC50:  3.81E+4nMAssay Description:The compound was evaluated for its inhibitory activity towards Protein tyrosine phosphatase of PTP-S2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 1A2(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50302542((R)-1-(4-Benzoyl-2-methylpiperazin-1-yl)-2-(1H-pyr...)
Affinity DataIC50: >4.00E+4nMAssay Description:Inhibition of recombinant CYP1A2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50302542((R)-1-(4-Benzoyl-2-methylpiperazin-1-yl)-2-(1H-pyr...)
Affinity DataIC50: >4.00E+4nMAssay Description:Inhibition of recombinant CYP2C9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50302542((R)-1-(4-Benzoyl-2-methylpiperazin-1-yl)-2-(1H-pyr...)
Affinity DataIC50: >4.00E+4nMAssay Description:Inhibition of recombinant CYP2D6More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50302542((R)-1-(4-Benzoyl-2-methylpiperazin-1-yl)-2-(1H-pyr...)
Affinity DataIC50: >4.00E+4nMAssay Description:Inhibition of recombinant CYP3A4 using benzyloxy-4-(trifluoromethyl)coumarin as substrateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50302542((R)-1-(4-Benzoyl-2-methylpiperazin-1-yl)-2-(1H-pyr...)
Affinity DataIC50: >4.00E+4nMAssay Description:Inhibition of recombinant CYP3A4 using 7-benzyloxyresorufin as substrateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 109 total ) | Next | Last >>
Jump to: